{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T01:20:02Z","timestamp":1769563202050,"version":"3.49.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"DOI":"10.2146\/ajhp140474","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T17:26:37Z","timestamp":1429032397000},"page":"707-710","source":"Crossref","is-referenced-by-count":13,"title":["Catheter-directed thrombolysis with alteplase and bivalirudin in a patient with heparin-induced thrombocytopenia"],"prefix":"10.1093","volume":"72","author":[{"given":"Larissa A.","family":"Martinez","sequence":"first","affiliation":[{"name":"University of New Mexico Hospital, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison E.","family":"Burnett","sequence":"additional","affiliation":[{"name":"University of New Mexico Hospital, and Clinical Assistant Professor, College of Pharmacy, University of New Mexico, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041008323338300_b1-0720707","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"issue":"suppl","key":"key\n\t\t\t\t2019041008323338300_b2-0720707","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"key\n\t\t\t\t2019041008323338300_b3-0720707","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","article-title":"Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia","volume":"108","author":"Warkentin","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041008323338300_b4-0720707","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2009-07-231506","article-title":"The severity of trauma determines the immune response to PF4\/heparin and the frequency of heparin-induced thrombocytopenia","volume":"115","author":"Lubenow","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041008323338300_b5-0720707","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/ATVBAHA.109.200766","article-title":"Indications for catheter-directed thrombolysis in the management of acute proximal deep venous thrombosis","volume":"30","author":"Patterson","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019041008323338300_b6-0720707","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t2019041008323338300_b7-0720707","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ajh.21367","article-title":"Argatroban and catheter-directed thrombolysis with alteplase for limb- and graft-threatening thromboses in a patient with a history of HIT","volume":"84","author":"Maldonado","year":"2009","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t2019041008323338300_b8-0720707","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ccd.21304","article-title":"Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia","volume":"70","author":"Turba","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"key\n\t\t\t\t2019041008323338300_b9-0720707","volume-title":"Safety of IVC filters with heparin-induced thrombocytopenia: a retrospective study","author":"Jung"},{"key":"key\n\t\t\t\t2019041008323338300_b10-0720707","first-page":"387","article-title":"Heparin-induced thrombocytopenia complicated with massive thrombosis of the inferior vena cava after filter placement","volume":"24","author":"Ishibashi","year":"2005","journal-title":"Int Angiol"},{"key":"key\n\t\t\t\t2019041008323338300_b11-0720707","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1111\/j.1538-7836.2011.04487.x","article-title":"Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series","volume":"9","author":"Warkentin","year":"2011","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t2019041008323338300_b12-0720707","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-9560-6-9","article-title":"Successful management of acute thromboembolic disease complicated with heparin induced thrombocytopenia type II (HIT II): a case series","volume":"6","author":"Serasli","year":"2008","journal-title":"Thromb J"},{"key":"key\n\t\t\t\t2019041008323338300_b13-0720707","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1345\/aph.1L194","article-title":"Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings","volume":"43","author":"Nutescu","year":"2009","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041008323338300_b14-0720707","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.thromres.2011.10.037","article-title":"Fondaparinux\u2014data on efficacy and safety in special situations","volume":"129","author":"Nagler","year":"2012","journal-title":"Thromb Res"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/72\/9\/707\/28320592\/ajhp0707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T08:53:31Z","timestamp":1566550411000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/72\/9\/707\/5111506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp140474","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,5,1]]},"published":{"date-parts":[[2015,5,1]]}}}